ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.610,27
0,69%
S&P 500
5.267,64
-0,19%
Dow Jones
38.421,92
-0,68%
Euro vs US Dollar
1,08862
0,31%
Bitcoin
69.191,04
2,13%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. RenovoRx Inc (RNXT)

  7. RenovoRx Inc (RNXT) News

RNXT

RenovoRx (RNXT)

RenovoRx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RNXT
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202414h30Business WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
21/05/202415h00Business WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
14/05/202415h00Business WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
13/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
13/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
10/05/202423h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/05/202422h50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
10/05/202422h47Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
02/05/202415h00Business WireRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:RNXTRenovoRx Inc
18/04/202414h30Business WireRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:RNXTRenovoRx Inc
16/04/202414h30Business WireRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
15/04/202414h00Business WireRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026NASDAQ:RNXTRenovoRx Inc
08/04/202414h30Business WireRenovoRx Announces $11.1 Million at Market Private PlacementNASDAQ:RNXTRenovoRx Inc
05/04/202414h30Business WireRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024NASDAQ:RNXTRenovoRx Inc
12/03/202414h00Business WireRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024NASDAQ:RNXTRenovoRx Inc
08/03/202422h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202422h26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202422h05Business WireRenovoRx Highlights Key Leadership PromotionsNASDAQ:RNXTRenovoRx Inc
13/02/202401h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
13/02/202401h39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
09/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
09/02/202422h15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RNXTRenovoRx Inc
06/02/202414h30Business WireRenovoRx CEO Issues Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
31/01/202401h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
31/01/202400h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
31/01/202400h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
31/01/202400h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
29/01/202415h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
29/01/202414h30Business WireRenovoRx Closes $6.1 Million Private PlacementNASDAQ:RNXTRenovoRx Inc
24/01/202403h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
 Showing the most relevant articles for your search:NASDAQ:RNXT

Kürzlich von Ihnen besucht

ASX
GSBG20
Australian Government Tr...
TSX
DAY
Ceridian HCM
AMEX
HCOM
Hartford Schroders Commo...
LSE
GMG
Game
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten